Calidi Biotherapeutics In...

AMEX: CLDI · Real-Time Price · USD
5.28
0.24 (4.76%)
At close: Aug 15, 2025, 3:59 PM
5.24
-0.76%
After-hours: Aug 15, 2025, 07:55 PM EDT

Calidi Biotherapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.41 -0.83 -3.39 -25.69
PEG Ratio
0.01 0.02 0.00 0.04
PS Ratio
n/a n/a 1.91K 625.63
PB Ratio
5.98 -2.94 -2.11 -12.42
P/FCF Ratio
-0.47 -0.88 -6.32 -217.95
P/OCF Ratio
-0.47 -0.9 -6.52 -259.41
OCF/S Ratio
n/a n/a -293.64 -2.41
Debt / Equity Ratio
4.59 -0.88 -0.15 -0.23
Quick Ratio
1.08 0.42 0.02 0.06
Current Ratio
1.08 0.42 0.02 0.06
Asset Turnover
n/a n/a 0.02 0.00
Interest Coverage
-23.34 -7.73 -146.38 -17.07
Return on Equity
-14.43 3.55 0.62 0.48
Return on Assets
-1.56 -2.92 -9.79 -0.05
Return on Invested Capital
-2.39 -16.96 0.66 -0.05
Dividend Yield
0.18 n/a n/a n/a
Payout Ratio
-0.08 n/a n/a n/a
Gross Profit Margin
n/a n/a -5.09 0.79
Net Profit Margin
n/a n/a -565.04 -24.35
Pretax Profit Margin
n/a n/a -564.8 -24.33
Operating Profit Margin
n/a n/a -513.96 -23.35
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a -555.51 -21.05